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Background: Genome-wide association studies found low plasma levels of 25-hydroxyvitamin D and vitamin D
receptor (VDR) polymorphisms associated with a higher prevalence of pathological changes in the intestine such as
chronic inflammatory bowel diseases.
Methods: In this study, a proteomic approach was applied to understand the overall physiological importance of
vitamin D in the small intestine, beyond its function in calcium and phosphate absorption.
Results: In total, 569 protein spots could be detected by two-dimensional-difference in-gel electrophoresis (2D-DIGE),
and 82 proteins were considered as differentially regulated in the intestinal mucosa of VDR-deficient mice compared to
that of wildtype (WT) mice. Fourteen clearly detectable proteins were identified by MS/MS and further analyzed by
western blot and/or real-time RT-PCR. The differentially expressed proteins are functionally involved in cell proliferation,
cell adhesion and cell migration, stress response and lipid transport. Mice lacking VDR revealed higher levels of
intestinal proteins associated with proliferation and migration such as the 37/67 kDa laminin receptor, collagen type VI
(alpha 1 chain), keratin-19, tropomyosin-3, adseverin and higher levels of proteins involved in protein trafficking and stress
response than WT mice. In contrast, proteins that are involved in transport of bile and fatty acids were down-regulated in
small intestine of mice lacking VDR compared to WT mice. However, plasma and liver concentrations of cholesterol and
triglycerides were not different between the two groups of mice.
Conclusion: Collectively, these data imply VDR as an important factor for controlling cell proliferation, migration and
stress response in the small intestine.
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Vitamin D is well known for its role in regulation of cal-
cium homeostasis and bone metabolism [1], but it also
exerts numerous other non-skeletal biological effects in
almost all tissues [2]. It is currently assumed that vitamin
D participates in the regulation of up to 5% of the human
genome [3]. One important target tissue of vitamin D is
the intestine where it regulates calcium and phosphate
absorption [4-6]. Non-skeletal vitamin D effects in the* Correspondence: gabriele.stangl@landw.uni-halle.de
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unless otherwise stated.intestine have been characterized mainly in the colon
and include the regulation of tight junction proteins in
the epithelial layer [7]. Vitamin D further modulates co-
lonic T-cell responses and inflammation processes [5,8-10],
and regulates the proliferation of intestinal cells in the
colon [11-13]. It should therefore be presumed that vita-
min D deficiency leads to mucosal dysregulation. The
observed associations of low vitamin D levels or VDR
deficiency with inflammatory bowel diseases in epidemi-
ologic studies [14-17], genome-wide association studies
[18] and experimental murine models [7,19-21], and the
linkage between vitamin D deficiency and colorectal cancer
[22,23] may reflect the proposed intestinal dysregulation
in response to vitamin D deficiency. Apart from theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of knowledge on the role of vitamin D in the small in-
testine, although the cells from the small intestine reveal
a higher VDR expression than most of the other tissues
[24]. The VDR is a nuclear receptor that mediates the
cellular effects of vitamin D by binding to vitamin D re-
sponse elements of target genes [25]. Therefore, mice
lacking VDR are an appropriate model to elucidate the
overall functions of vitamin D in selected tissues [26].
To target the gap of knowledge on vitamin D function
in the small intestine, we performed quantitative com-
parative protein expression profiling of the small intes-
tinal mucosa of VDR knockout (KO) versus wildtype
(WT) mice by applying two-dimensional-difference in-
gel electrophoresis (2D-DIGE) in combination with ESI-
QTOF-MS/MS.
Results
Analysis and identification of differentially
expressed proteins
In order to determine the differential protein expression
pattern of the small intestinal mucosa of VDR-KO and
WT mice, protein extracts were analyzed by 2D-DIGE. In
total, 569 protein spots could be detected on the resulting
consensus 2D gel. Comparative analysis of the protein ex-
pression profiles revealed that 82 protein spots can
be classified differentially expressed (by a regulation
factor > 2.0 (up- or down-regulated)) between VDR-KO
and corresponding WT mice. 19 spots could be assigned
to 14 unique proteins by MS/MS identification (Table 1).
A representative 2D gel image is shown in Figure 1 and
direct spot comparisons are shown in Figure 2. Three
spots were identified as β-actin with various pIs and mo-
lecular weights. Also, 94 kDa glucose-regulated protein
(GRP94), heat shock cognate 71 kDa protein (Hsc70) and
keratin-19 (K19) were detected in multiple spots which
may represent post-translationally modified forms of these
proteins. Proteins that were up-regulated in small intestinal
mucosa of VDR-KO compared to WT mice included pro-
teins that are involved in cell adhesion (37/67 kDa laminin
receptor (37/67LR), collagen type VI (alpha 1 chain) (Col
6a1)), cytoskeleton proteins (tropomyosin-3 (Tpm3), adse-
verin, K19), stress response and protein trafficking proteins
(GRP94, valosin-containing protein (VCP/p97)) and the
proteasome activator subunit 2 (PA28β). Proteins that were
down-regulated in VDR-KO compared to WT mice are
two lipid transport proteins (ileal lipid-binding protein
(ILBP), intestinal fatty acid-binding protein (I-FABP)), the
cytoskeleton component β-actin, the 14-3-3 protein iso-
form ζ/δ, the heat shock cognate protein Hsc70 and
6-phosphogluconolactonase (6PGL). Note, PA28β and
6PGL failed to overcome the Mascot significance level of
56 and may therefore be indefinite despite adequate se-
quence coverage.Verification of 2D-DIGE data by western blotting and RT-PCR
To verify the 2D-DIGE results, the 37/67LR protein ex-
pression was analyzed by western blot analysis. 37/67LR
was chosen because of its tenfold higher expression in
VDR-KO compared to WT mice. Western blot analysis
revealed that protein expression of 37/67LR was about
fivefold higher in the small intestinal mucosa of VDR-
KO than in the mucosa of WT mice (Figure 3), thus in-
deed supporting the initial proteomic profiling results.
To analyze whether the observed differences in protein
expression between the VDR-KO and the WT mice were
linked to changes in the mRNA levels, we determined the
relative mRNA concentrations of the corresponding genes.
Here we show that the relative mRNA abundances of
β-actin, Col6a1 and 14-3-3 protein ζ/δ were in line with
protein expression data (Table 1). The intestinal mRNA
abundances of GRP94 and PA28β which were slightly lower
in the VDR-KO mice than in the WT mice completely dif-
fered from the protein data, and the mRNA abundances of
seven other genes were not different between VDR-KO and
WT mice, assuming post-transcriptional effects which are
responsible for the discrepancy between mRNA and pro-
tein data (Table 1). As indicated in Figure 4, no difference
in relative mRNA concentration of 37/67LR was found
in small intestinal mucosa of VDR-KO and WT mice.
Increased expression of the membrane form of 37/67LR
is associated with increased mRNA expression and activity
of matrix metalloproteinase (MMP)-2 [27]. Therefore, we
also analyzed the mRNA abundance of MMP-2. Data re-
veal that mRNA-concentration of MMP-2 was higher in
the small intestine of VDR-KO mice than in small intes-
tine of WT mice (1.7-fold; p < 0.01; Figure 4).
Lipid concentrations in plasma and liver
Triglyceride and cholesterol concentrations of plasma and
liver did not differ between VDR-KO and WT mice (tri-
glycerides in plasma: VDR-KO, 1.85 ± 0.31 mmol/l, WT,
1.71 ± 0.48 mmol/l; liver triglycerides: VDR-KO, 60.3 ±
8.4 μmol/g, WT, 57.9 ± 8.8 μmol/g; cholesterol in plasma:
VDR-KO, 3.34 ± 0.28 mmol/l, WT, 3.39 ± 0.54 mmol/l;
liver cholesterol: VDR-KO, 10.9 ± 1.4 μmol/g, WT, 12.4 ±
2.4 μmol/g).
Discussion
This study aimed to investigate the role of the vitamin D
on small intestinal mucosa proteins by use of VDR-KO
mice and 2D-DIGE analysis. Here we could identify 14
proteins that were differently expressed in VDR-KO and
WT mice indicating a direct or indirect involvement of
VDR in regulation of these proteins. The identified pro-
teins are involved in cell proliferation, cell migration and
stress response.
Intestinal integrity is governed by a variety of signaling
pathways that balance cell proliferation and differentiation.
Table 1 Differentially expressed proteins and mRNA abundances of genes in the small intestinal mucosa of VDR-KO relative to WT mice
UniProtAcc. Protein Spot no. Fold changea No. of peptides Coverage (%) pI (theor.) Mascot score mRNA fold changea Function
P14206 37/67 kDa laminin
receptor (37/67LR)
16 +10.8 9 39 4.80 422 n.s. Membrane receptor for laminin
P08113 94 kDa glucose-regulated
protein (GRP94)
18, 19 +5.0, +5.5 22 28 4.74 307 −1.4* Chaperone, stress response
P21107 Tropomyosin 3 (Tpm3) 13 +4.3 11 28 4.68 225 n.d. Cytoskeleton
Q04857 Collagen type VI
(alpha 1 chain) (Col6a1)
1 +4.2 9 10 5.20 88 +1.8* Extracellular matrix protein
Q01853 Valosin-containing
protein(VCP/p97)
17 +3.8 18 28 5.14 204 n.s. Chaperon, stress response,
protein degradation
P97372 Proteasome activator
complex subunit 2 (PA28β)
8 +3.1 8 40 5.54 35c −1.6* Proteasome activation
P19001 Keratin, type I
cytoskeletal 19 (K19)
14, 15 +2.1, +2.9 14 39 5.28 127 n.s. Cytoskeleton
Q60604 Adseverin 2 +2.8 18 30 5.46 88 n.s. Cytoskeleton
P60710 β-actin 5, 6, 7 −6.5, −4.2-4.1 5 15-21 5.29b 54-70 −2.0* Cytoskeleton
Q9CQ60 6-phosphogluconolactonase
(6PGL)
9 −2.7 3 15 5.55 39c n.s. Carbohydrate metabolism
P63017 Heat shock cognate
71 kDa protein (Hsc70)
3, 4 −2.5, −2.6 31 52 5.37 586 n.s. Chaperone, stress response
P51162 Ileal lipid-binding
protein (ILBP)
10 −2.5 8 68 5.91 210 n.d. Lipid metabolism
P55050 Fatty acid-binding
protein 2 (I-FABP)
11 −2.4 4 31 6.62 102 n.s. Lipid metabolism
P63101 14-3-3 protein ζ/δ 12 −2.3 18 63 4.73 353 −1.6* Signal transduction






















Figure 1 2D spot pattern of analytical gels. A) Gels are composed of small intestinal mucosa of vitamin D receptor knockout (VDR-KO) and
corresponding wildtype (WT) mice. In total, 15 μg of fluorescence labeled proteins were subjected to 2D-DIGE. B) Enlarged sections showing
selected spots of the analytical gel in A). For spot description, see Table 1.
Figure 2 Representative spot comparison of differentially expressed proteins of vitamin D receptor knockout and wildtype mice.
Regulated and identified proteins from small intestinal mucosa of vitamin D receptor knockout (VDR-KO, left) mice are pictured in comparison to
their respective wildtype (WT) mice (right) counterpart. Spot number is given in brackets.
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Figure 3 Western blot analysis of 37/67 kDa laminin receptor. A) Protein expression of 37/67 kDa laminin receptor (37/67LR) of small
intestinal mucosa samples of vitamin D receptor knockout (VDR-KO) and wildtype (WT) mice are represented as means ± s.d. (n = 6). *Significantly
different from WT mice (p < 0.05, Student’s t-test). B) Representative immunoblot of 37/67LR and GAPDH from small intestinal mucosa samples of
VDR-KO and WT mice.
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acterized by continuous proliferation of crypt epithelial
cells, migration of the cells along the crypt-villus axis and
extrusion at the villus tip. Cell migration requires cycles of
polarized attachment of cells to the underlying matrix, and
the establishment of the polarized state. Regulated re-
arrangements of the cytoskeleton and coordinated intra-
cellular trafficking of organelles and membrane proteins
are important steps in these processes. Here, we found
that VDR deficiency is associated with the up-regulation
of proteins that are involved in processes of proliferation
and migration of epithelial cells in the small intestine.Figure 4 Relative mRNA levels of 37/67 kDa laminin receptor
(37/67LR) and matrix-metalloproteinase-(MMP)-2. Relative mRNA
levels in small intestinal mucosa of vitamin D receptor knockout
(VDR-KO) and wildtype (WT) mice were determined by real-time
detection RT-PCR analysis. Expression values were normalized to HPRT
and Ppia. Bars represent means ± s.d. (n = 6). *Significantly different
from WT mice (p < 0.05, Student’s t-test).These include 37/67LR, Col6a1, Tpm3, adseverin, K19 and
GRP94. Among those proteins, the strongest change was
observed for 37/67LR, which functions in its membrane
bound form as a non-integrin receptor for the basement
membrane glycoprotein laminin [28,29]. 37/67LR is over-
expressed in a variety of common cancers and its expres-
sion level correlates with aggressiveness and metastatic
potential [29]. Recent data demonstrate that 37/67LR pre-
dominantly appears in the undifferentiated/proliferative re-
gion of the human intestinal crypt and regulates adhesion
and proliferation of epithelial cells [30]. We assume that
the strong expression of 37/67LR in the VDR-KO mice
might reflect a disturbed balance between cell proliferation
and differentiation in favor of proliferation. This confirms
the anti-proliferative function of vitamin D and VDR
which has been described for the colon and colon car-
cinoma cells [31,32]. The finding that the mRNA ex-
pression of MMP-2 was also enhanced corroborates the
high abundance of 37/67LR in the small intestine of
mice lacking VDR [27]. However, increased protein ex-
pression of 37/67LR was not associated with increased
mRNA levels indicating posttranscriptional regulation.
A second protein that was up-regulated in the VDR-KO
mice was Col6a1. Collagen VI functions as a bona fide basal
lamina component in the intestine, and is involved in epi-
thelial cell behavior and cell-fibronectin interactions [33].
Besides cellular adhesion components, also cytoskeletal
components were up-regulated in the intestine of VDR-
KO mice. K19, that belongs to one of those up-regulated
cytoskeletal proteins, functions as an intermediate fila-
ment mainly in proliferating crypt cells [34] and is associ-
ated with a less differentiated phenotype of Caco-2-cells
[35]. Tpm3 and the gelsolin-family member adseverin are
two other differentially expressed proteins which are in-
volved in actin-filament assembly and turnover [36,37]. In
the context of an altered expression of β-actin in the small
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in the regulation of actin-filament dynamics in these ani-
mals, and confirm other studies that found vitamin D in-
volved in modulation of cytoskeletal protein expression in
e.g. muscle cells [38] and cell lines [39,40].
Vitamin D is supposed to be involved in reducing oxida-
tive cell and endoplasmic reticulum (ER) stress [41-43], and
colon cells of VDR-KO mice show higher levels of bio-
markers for oxidative stress than those of WT mice [32].
The current study found a couple of differentially expressed
stress response proteins in the small intestine of VDR-KO
mice compared to WT mice that may underline the vita-
min D function in stress response. In particular, we ob-
served alterations in the intestinal expression of GRP94, a
member of the HSP90 family, the ATP-driven VCP/p97,
Hsc70, a molecular chaperone of the HSP70 family, and
the proteasome activator subunit PA28β in mice lacking
VDR compared to WT mice. These proteins are involved
in adaptive mechanisms to stress response, especially in
processing misfolded proteins (ubiquitination, refolding)
[44-47]. Since the small intestine is normally exposed to
a multitude of stressors like harmful nutritional compo-
nents, microorganisms, toxins and luminal antigens, it can
be speculated that vitamin D may modify the response to
cells to those stressors.
The multifunctional protein 14-3-3ζ/δ was less expressed
in small intestine of VDR-KO than of WT mice. Proteins of
the 14-3-3 family are highly conserved eukaryotic proteins
that regulate many cellular processes by altering the con-
formation, activity or subcellular localization of target pro-
teins, e.g. cytoskeletal components [48-50]. Interestingly,
14-3-3ζ/δ is also involved in regulation of Wnt/β-catenin
signaling in intestinal stem cells, a pathway that is impli-
cated in intestinal development and regeneration [51], and
that has been associated with the differentiation-promoting
effect of vitamin D/VDR in colon carcinoma cells [23,52].
Besides alterations in proteins involved in cell prolifer-
ation, cell migration, cytoskeletal organization and stress
response, the small intestine of VDR-KO mice showed
reduced expression of ILBP and I-FABP, proteins that
are involved in lipid metabolism and transport. Recent
findings show an enlarged size of total bile acid pool, a
stimulated bile acid synthesis and a reduced gene ex-
pression of bile acid transporters in the liver but not in
intestine of VDR-KO compared to WT mice [53]. In that
study, analyzed mRNA expression levels of ILBP show no
differences between VDR-KO and WT mice which is
confirmed by our results. Nevertheless, our study shows
reduced protein expression of ILBP in VDR-KO mice
indicating the involvement of post transcriptional mecha-
nisms in regulation of ILBP. Expression of ILBP is stimu-
lated by bile acid concentration [54], thus local differences
in bile acid concentration may account for reduced ILBP
protein expression in intestine of VDR-KO mice. FABP isusually involved in the transport of long chain fatty acids
into enterocytes [55]. Despite the observed reduction in
protein levels of FABP in the VDR-KO mice compared to
the WT mice, we found no differences in plasma and liver
lipids between these two groups of mice. These data con-
firm recently published data that show comparable fatty
acid absorption rates between VDR-KO and WT mice
[56]. We therefore assume that the diminished expression
of both transporters may not induce obvious disturbances
in lipid metabolism.
Conclusions
Collectively, these data imply that the small intestine of
mice lacking VDR expresses higher levels of proteins that
are principally involved in cell proliferation, cell migration
and stress response than corresponding WT mice. Thus,
we can conclude that vitamin D may play a direct or an
indirect role in balancing cell proliferation, cell migration
and stress response in the small intestine.
Methods
Animals and study design
Six 12 to 15-week-old male vitamin D receptor knockout
mice (VDR-KO; B6.129S4-VDRtm1Mbd>/J; Jackson La-
boratory, Bar Habor, USA) and six age-matched male
wildtype (WT) mice (C57BL/6 J, Charles River, Sulzfeld,
Germany) were fed a rescue diet containing 2% calcium
and 1.25% phosphorus. Other basal components of the
diet were (in g/kg) casein (200), sucrose (200), lactose (200),
starch (49.5), coconut fat (200), soybean oil (10), cholesterol
(1.5), cellulose (50), DL-methionine (2), vitamin and min-
eral mixture (87), containing 1,000 IU vitamin D3. All mice
were kept individually in a room controlled for temperature
(22 ± 2°C), relative humidity (50–60%) and a 12-h light,
12-h dark cycle. All mice were allowed free access to
food and water. The experimental procedures described
followed established guidelines for the care and hand-
ling of laboratory animals and were approved by the
council of Saxony-Anhalt (approval number: 42502-5-
34 MLU).
Sample collection
Prior to killing by decapitation under light anesthesia with
diethyl ether all mice were food deprived for 10 hours.
Blood was collected into EDTA tubes. Plasma was ob-
tained by centrifugation at 1,500 g for 20 min and stored
at −20°C. The small intestine (from pylorus to ileocecal
valve) was completely excised and washed several times
with cold NaCl solution (0.9%). Intestinal mucosa was
harvested by scraping the surface of the small intestine.
Obtained mucosa samples were snap-frozen in liquid
nitrogen and stored at −80°C. The liver was excised and
samples for lipid extraction were snap-frozen and stored
at −80°C as well.
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For isoelectric focusing (IEF), protein extracts of small
intestinal mucosa of each mouse were prepared. Therefore,
20 mg of frozen small intestinal mucosa were mechanically
disrupted (MPI FastPrep®24-System, MP Biomedicals LLC,
Illkirch Cedex, France) in 200 μl of 50 mM Tris–HCl
buffer (pH 7.5) containing protease inhibitor cocktail
(1:100, Roche, Mannheim Germany). Crude homogenates
were centrifuged for 15 min (16,000 g, 4°C), the superna-
tants were collected and protein concentrations were
determined according to Bradford [57]. For subsequent
fluorescence labeling and IEF, the samples were pooled
group-wise at equal protein amounts and the resulting
protein solutions were cleaned using the ReadyPrep™ 2D
Cleanup Kit (Bio-Rad, Munich, Germany) according to the
manufacturer’s protocol. The resulting protein precipitate
was resuspended in a 2D compatible buffer (7 M Urea,
2 M thiourea, 4% CHAPS, 30 mM Tris–HCl, pH 8.5). Pro-
tein concentrations of the resuspended solutions were
measured in dilution to discriminate urea interferences.
2D-DIGE analysis
Protein pools were labeled with fluorescence dyes using
the Refraction-2D Kit (NH DyeAGNOSTICS GmbH,
Halle (Saale), Germany) according to the manufacturer’s
instructions. The internal standard consisted of homoe-
quivalent amounts of protein from VDR-KO and WT
mice. For analytical gels, 5 μg of labeled protein per
animal group along with 5 μg of the internal standard
were pooled and mixed with DeStreak rehydration buffer
(GE Healthcare, Munich, Germany) containing 0.5%
carrier ampholytes (pH 4–7, SERVA Electrophoresis,
Heidelberg, Germany) and added to immobilized pH gra-
dient strips (pH 4–7, 7 cm, linear, Bio-Rad, Munich,
Germany) for passive sample loading overnight at room
temperature. Preparative gels were loaded with 300 μg of
total protein that was spiked with labeled protein for
the subsequent matching process with analytical gels.
First dimension IEF was run on a Protean IEF Cell (Bio-
Rad, Munich, Germany) followed by a two step equilibra-
tion process using equilibration buffer (50 mM Tris–HCl
(pH 8.8), 6 M Urea, 2% SDS, 30% glycerol, bromophenol
blue) supplemented with 2% DTT (step 1) or 2.5% iodoa-
cetamide (step 2), and incubating the stripes for 15 min,
respectively. Thereafter, proteins were separated using lin-
ear SDS-PAGE (12.5%) and fixed (50% ethanol, 10% acetic
acid) for 1 h. The samples were processed in six replicates.
For preparative gels, the fixation step was omitted and the
fluorescence signal was recorded directly before staining
with colloidal Coomassie blue [58]. Fluorescence signal ac-
quisition was achieved using a Typhoon Trio laser scanner
(GE Healthcare, Munich, Germany). Gel analysis was per-
formed with the Delta2D software (Decodon, Greifswald,
Germany). Protein spots that showed a regulation factor ofat least 2 between the two groups were considered for fur-
ther analysis.
Protein identification by ESI-QTOF-MS/MS-analysis
Protein spots were excised from Coomassie-stained gels,
washed, and digested with trypsin (Promega, Mannheim,
Germany) in 10 μl of 10 mM ammonium bicarbonate
(pH 8.0) overnight at 37°C. Peptides were extracted from
gel pieces and injected into a nanoACQUITY UPLC sys-
tem (Waters Co., Eschborn, Germany). 2 μl were injected
via “microliter pickup” mode and desalted on-line through
a symmetry C18 180 μm× 20 mm precolumn. The pep-
tides were separated on a 100 μm× 100 mm analytical RP
column (1.7 μm BEH 130 C18, Waters Co., Eschborn,
Germany) using a typical UPLC gradient from 3.0 to
33.0% over 15 min and a flow rate of 600 nl/min. The mo-
bile phases used were 0.1% formic acid in water and 0.1%
formic acid in acetonitrile. The column was connected to
a SYNAPT® G2 HDMS-mass spectrometer (Waters Co,
Eschborn, Germany). The data were acquired in LC/MSE
mode switching between low and elevated energy on al-
ternate scans. Subsequent correlation of precursor and
product ions can then be achieved using both retention
and drift time alignment. Using ProteinLynx Global SER-
VER 2.5.2 data were processed and searched against the
SwissProt database specified for Mus musculus using
Mascot search engine of Matrix Science [59].
Western blot analysis
Standard western blot procedure was performed as de-
scribed earlier [60]. Small intestinal mucosa samples were
prepared as described above and 30 μg of protein of each
individual mouse were resolved by electrophoresis in
12% SDS-PAGE gels. Membranes were incubated with
anti-67 kDa laminin receptor antibody (1:1000; Abcam,
Cambridge, UK; ab133645) and anti-GAPDH antibody
(1:1000; Cell Signaling, Boston MA, USA; #5174S) re-
spectively and subsequently detected with secondary
HRP-conjugated antibody (1:1000; anti-rabbit IgG, Cell
Signaling) using ECL Prime western blotting detection
reagent (GE Healthcare, Munich, Germany).
Real-time detection RT-PCR analysis
Total RNA was isolated from aliquots of mice small intes-
tinal mucosa by peqGold Trifast™ reagent (Peqlab, Erlangen,
Germany) according to the manufacturer’s protocol. cDNA
synthesis and determination of mRNA abundance by real-
time detection PCR (Rotor-Gene 6000, Corbett Research,
Mortlake, Australia) were performed as described previ-
ously [61]. Calculation of the relative mRNA concentrations
was performed according to [62]. PCR data were normal-
ized to the reference genes hypoxanthine guanine phos-
phoribosyl transferase (HPRT) and peptidylprolyl isomerase
A (Ppia). The following target-specific primers were used
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(NM_008907, Ppia), for, 5′-GTGGTCTTTGGGAAGG
TGAA-3′, rev, 5′-TTACAGGACATTGCGAGCAG-3′;
37/67 kDa laminin receptor (NM_011029, Rpsa), for, 5′-
CTTGACGTCCTGCAGATGAA-3′, rev, 5′-GGATTCTC-
GATGGCAACAAT-3′ and matrix metalloproteinase
(MMP)-2 (NM_008610.2, Mmp2), for, 5′-GAGATCT
TCTTCTTCAAGGAC-3′, rev, 5′-AATAGACCCAG-
TACTCATTCC-3′, β-actin (NM_007393, Actb), for,
5′- ACGGCCAGGTCATCACTATTG −3′, rev, 5′-
CACAGGATTCCATACCCAAGAAG −3′. All other
primer pairs were purchased from Sigma-Aldrich
(www.kicqstart-primers-sigmaaldrich.com).
Lipid analysis
Liver lipids were extracted using a mixture of n-hexane
and isopropanol (3:2, v:v) [63]. Aliquots of lipid extracts
were dried and dissolved in a small volume of Triton
X-100 [64]. Concentrations of total cholesterol and tri-
glycerides were determined as described previously [65].
Statistical analysis
Data are presented as means ± standard deviation (s.d.).
Means of VDR-KO and WT mice were compared by
Student’s t-test using the Minitab Statistical software,
version 13 (Minitab, State College, USA). Means were
considered significantly different at p < 0.05.
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